291 related articles for article (PubMed ID: 29992681)
1. Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcare.
Bretherton I; Thrower E; Grossmann M; Zajac JD; Cheung AS
Intern Med J; 2019 Feb; 49(2):182-188. PubMed ID: 29992681
[TBL] [Abstract][Full Text] [Related]
2. Position statement on the hormonal management of adult transgender and gender diverse individuals.
Cheung AS; Wynne K; Erasmus J; Murray S; Zajac JD
Med J Aust; 2019 Aug; 211(3):127-133. PubMed ID: 31271465
[TBL] [Abstract][Full Text] [Related]
3. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
4. Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial.
Burinkul S; Panyakhamlerd K; Suwan A; Tuntiviriyapun P; Wainipitapong S
J Sex Med; 2021 Jul; 18(7):1299-1307. PubMed ID: 34274044
[TBL] [Abstract][Full Text] [Related]
5. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
[TBL] [Abstract][Full Text] [Related]
6. Hematology reference intervals for transgender adults on stable hormone therapy.
Greene DN; McPherson GW; Rongitsch J; Imborek KL; Schmidt RL; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
Clin Chim Acta; 2019 May; 492():84-90. PubMed ID: 30771301
[TBL] [Abstract][Full Text] [Related]
7. Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women.
Haupt C; Henke M; Kutschmar A; Hauser B; Baldinger S; Saenz SR; Schreiber G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013138. PubMed ID: 33251587
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
Arnold JD; Sarkodie EP; Coleman ME; Goldstein DA
J Sex Med; 2016 Nov; 13(11):1773-1777. PubMed ID: 27671969
[TBL] [Abstract][Full Text] [Related]
9. Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients: A Systematic Review.
Boskey ER; Taghinia AH; Ganor O
JAMA Surg; 2019 Feb; 154(2):159-169. PubMed ID: 30516808
[TBL] [Abstract][Full Text] [Related]
10. Subcortical gray matter changes in transgender subjects after long-term cross-sex hormone administration.
Seiger R; Hahn A; Hummer A; Kranz GS; Ganger S; Woletz M; Kraus C; Sladky R; Kautzky A; Kasper S; Windischberger C; Lanzenberger R
Psychoneuroendocrinology; 2016 Dec; 74():371-379. PubMed ID: 27744092
[TBL] [Abstract][Full Text] [Related]
11. Effects of cross-sex hormone treatment on transgender women and men.
Deutsch MB; Bhakri V; Kubicek K
Obstet Gynecol; 2015 Mar; 125(3):605-610. PubMed ID: 25730222
[TBL] [Abstract][Full Text] [Related]
12. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
13. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
[TBL] [Abstract][Full Text] [Related]
14. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
Vita R; Settineri S; Liotta M; Benvenga S; Trimarchi F
Maturitas; 2018 Jan; 107():92-96. PubMed ID: 29169588
[TBL] [Abstract][Full Text] [Related]
15. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
Spanos C; Bretherton I; Zajac JD; Cheung AS
World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
[TBL] [Abstract][Full Text] [Related]
16. Early Access to Testosterone Therapy in Transgender and Gender-Diverse Adults Seeking Masculinization: A Randomized Clinical Trial.
Nolan BJ; Zwickl S; Locke P; Zajac JD; Cheung AS
JAMA Netw Open; 2023 Sep; 6(9):e2331919. PubMed ID: 37676662
[TBL] [Abstract][Full Text] [Related]
17. Progesterone Is Important for Transgender Women's Therapy-Applying Evidence for the Benefits of Progesterone in Ciswomen.
Prior JC
J Clin Endocrinol Metab; 2019 Apr; 104(4):1181-1186. PubMed ID: 30608551
[TBL] [Abstract][Full Text] [Related]
18. People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge.
Mepham N; Bouman WP; Arcelus J; Hayter M; Wylie KR
J Sex Med; 2014 Dec; 11(12):2995-3001. PubMed ID: 25213018
[TBL] [Abstract][Full Text] [Related]
19. Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.
Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Dickerson JA; Drees JC; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2021 Jan; 6(1):15-26. PubMed ID: 32674116
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
